Licensing is critical to maintaining a robust pipeline. However, competition for early- and late-stage compounds and medical products is tremendous, which means that if you’re slow to identify and strike deals, you could lose out on opportunities.
ZS accelerates the creation of business development strategies and ensures that potential opportunities are well evaluated and aligned with portfolio and strategic priorities. We help prioritize promising therapy areas and products; conduct rapid analytics for go/no-go decisions; and provide rigorous commercial due diligence and valuation. Our integrated approach allows you to answer time-sensitive strategic questions.
ZS's BD&L Services help you:
Managers and executives involved in the commercialization of new products will benefit from this webinar for medical products and devices organizations.